Edition:
United Kingdom

People: Aeterna Zentaris Inc (AEZS.OQ)

AEZS.OQ on NASDAQ Stock Exchange Capital Market

2.53USD
17 Jul 2019
Change (% chg)

$-0.07 (-2.69%)
Prev Close
$2.60
Open
$2.56
Day's High
$2.63
Day's Low
$2.53
Volume
12,700
Avg. Vol
32,912
52-wk High
$5.56
52-wk Low
$1.30

Auld, Leslie 

Ms. Leslie Auld is Chief Financial Officer, Senior Vice President of the Company. Ms. Auld has over twenty-five years of accounting, finance and pharmaceutical industry experience, with increasingly senior roles at PricewaterhouseCoopers, Helix BioPharma Corp., Luminex Diagnostics (formerly TM BioScience Corp.), Attwell Capital Inc. (formerly Fralex Therapeutics) and GeneNews Limited. A Chartered Professional Accountant, Ms. Auld graduated with an Honours Bachelor of Science, Pharmacology & Toxicology from the University of Western Ontario, and has a Master of Business Administration degree from the University of Toronto.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --